Skip to main content
. 2021 Jun 29;5(9):bvab120. doi: 10.1210/jendso/bvab120

Table 1.

Patient characteristics in the development and validation cohorts

Development cohort Validation cohort
TPP (n = 39) HypoK control (n = 502) P TPP (n = 11) non-TPP (n = 36) P
Sex, male 39 (100.0%) 502 (100.0%) 11 (100.0%) 36 (100.0%)
Age, y 34.7 ± 8.4 47.1 ± 10.5 < .001 35.9 ± 7.8 52.8 ± 13.1 < .001
ECG-K + , mEq/L 2.6 ± 0.6 3.0 ± 0.5 .106
Weakness 39(100.0%) 50(10.0%) < .001 11(100.0%) 36(100.0%)
ECG morphology
 Heart rate 95.1 ± 17.5 91.5 ± 21.7 .306 100.0 ± 10.1 85.3 ± 14.6 .003
 PR interval 176.0 ± 33.2 162.1 ± 37.1 .025 166.1 ± 57.3 166.6 ± 40.5 .674
 QRS duration 101.6 ± 10.8 102.3 ± 17.9 .806 96.5 ± 11.1 110.2 ± 26.0 .094
 QT interval 384.3 ± 76.0 395.1 ± 55.8 .257 364.6 ± 29.3 399.2 ± 47.4 .023
 Correct QT interval 476.1 ± 81.2 480.0 ± 50.4 .662 470.2 ± 43.2 471.4 ± 46.0 1.000
 P waves axes 65.0 ± 60.6 54.8 ± 30.7 .074 51.5 ± 68.6 53.1 ± 32.4 .905
 RS waves axes 57.2 ± 23.3 47.5 ± 49.6 .227 47.9 ± 28.7 47.4 ± 35.9 .950
 T waves axes 47.5 ± 79.9 42.8 ± 63.5 .670 17.7 ± 50.8 49.3 ± 77.3 .407
Laboratory test
 TSH, μIU/mL 0.0 ± 0.1 1.3 ± 1.2 < .001 0.0 ± 0.0 1.8 ± 1.4 .004
 Free T4, ng/dL 2.5 ± 0.6 1.0 ± 0.3 < .001 2.7 ± 0.5 1.1 ± 0.1 .003
 eGFR, mL/min 146.2 ± 54.6 90.4 ± 59.5 < .001 156.1 ± 43.7 91.3 ± 45.6 < .001
 Cr, mg/dL 0.8 ± 0.6 1.7 ± 2.3 .019 0.7 ± 0.2 1.6 ± 2.3 < .001
 BUN, mg/dL 18.0 ± 15.2 18.8 ± 15.5 .748 11.7 ± 3.7 19.9 ± 16.3 .117
 K+, mEq/L 2.5 ± 0.6 2.8 ± 0.2 < .001 2.5 ± 0.5 2.7 ± 0.3 .027
 Na+, mEq/L 139.2 ± 2.2 136.1 ± 5.0 < .001 139.3 ± 1.2 137.6 ± 5.0 .454
 Cl, mEq/L 106.7 ± 2.3 99.4 ± 7.6 < .001 108.0 ± 2.1 101.3 ± 7.4 .005
 Ca++, mg/dL 8.8 ± 0.7 8.5 ± 0.8 .024 8.9 ± 0.6 8.1 ± 0.9 .003
 Mg++, mg/dL 1.9 ± 0.3 1.9 ± 0.4 .334 2.0 ± 0.2 1.8 ± 0.5 .541

Abbreviations: BUN, blood urea nitrogen; Ca++, total calcium; Cl, chloride; Cr, creatinine; ECG, electrocardiography; ECG-K+, K+ estimated via electrocardiography; eGFR, estimated glomerular filtration rate; Free T4, free thyroxine; HypoK, hypokalemia; K+, potassium; Mg++, magnesium; Na+, sodium; TSH, thyrotropin; TPP, thyrotoxic periodic paralysis.